NICOLE DANIELS: Open Payments
NPI 1134900996 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 13 payments from 10 companies in 2025. Trend: 2023 $366 · 2024 $595 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $76 |
| Antares Pharma, Inc. | 2 | $51 |
| Boston Scientific Corporation | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| UROGEN PHARMA, INC. | 1 | $27 |
| Verity Pharmaceuticals Inc. | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Telix Pharmaceuticals | 1 | $20 |
| Endo USA, Inc. | 1 | $18 |
Products named: XYOSTED, ADSTILADRIN, PROVENGE, JELMYTO, Trelstar, GEMTESA, LithoVue, ILLUCCIX.
Industry payments across NC — which companies pay providers there.
